Abstract
Objectives
The non-invasive assessment of left ventricular (LV) diastolic dysfunction remains a challenge. The role of first-pass perfusion cardiac magnetic resonance (CMR) parameters in quantitative hemodynamic analyses has been reported. We therefore aimed to validate the diagnostic ability and accuracy of such parameters against cardiac catheterization for LV diastolic dysfunction in patients with left heart disease (LHD).
Methods
We retrospectively enrolled 77 LHD patients who underwent CMR imaging and cardiac catheterization. LV diastolic dysfunction was defined as pulmonary capillary wedge pressure (PCWP) or LV end-diastolic pressure (LVEDP) > 12 mmHg on catheterization. On first-pass perfusion CMR imaging, pulmonary transit time (PTT) was measured as the time for blood to pass from the left ventricle to the right ventricle (RV) through the pulmonary vasculature. Pulmonary transit beat (PTB) was the number of cardiac cycles within the interval, and pulmonary blood volume indexed to body surface area (PBVi) was the product of PTB and RV stroke volume index (RVSVi).
Results
Of the 77 LHD patients, 53 (68.83%) were found to have LV diastolic dysfunction, and showed significantly higher PTTc, PTB, and PBVi (p < 0.05) compared with those without. In multivariate analyses, only PTTc and PTB were identified as independent predictors of LV diastolic dysfunction (p < 0.05). With an optimal cutoff of 11.9 s, PTTc yielded the best diagnostic performance for LV diastolic dysfunction (area under the curve = 0.83, p < 0.001).
Conclusions
PTTc may represent a non-invasive quantitative surrogate marker for the detection and assessment of diastolic dysfunction in LHD patients.
Key Points
• PTTc yielded the best diagnostic accuracy for diastolic dysfunction, with an optimal cutoff of 11.9 s, and a specificity of 100%.
• PTTc and PTB were found to be independent predictors of LV diastolic dysfunction across different multivariate models with high reproducibility.
• PTTc is a promising non-invasive surrogate marker for the detection and assessment of diastolic dysfunction in LHD patients.
Similar content being viewed by others
Abbreviations
- CMR:
-
Cardiac magnetic resonance
- CoV:
-
Coefficient of variation
- DBP:
-
Diastolic blood pressure
- dPAP:
-
Diastolic pulmonary artery pressure
- HF:
-
Heart failure
- ICC:
-
Intra-class correlation coefficient
- LHD:
-
Left heart disease
- LV:
-
Left ventricular
- LVEDP:
-
LV end-diastolic pressure
- mPAP:
-
Mean pulmonary artery pressure
- mRAP:
-
Mean right atrial pressure
- NYHA:
-
New York Heart Association
- PBVi:
-
Pulmonary blood volume indexed to body surface area
- PCWP:
-
Pulmonary capillary wedge pressure
- PTB:
-
Pulmonary transit beats
- PTT:
-
Pulmonary transit time
- ROC:
-
Receiver operating characteristic
- ROI:
-
Region of interest
- RV:
-
Right ventricular
- RVSVi:
-
RV stroke volume index
- SBP:
-
Systolic blood pressure
- SI:
-
Signal intensity
- sPAP:
-
Systolic pulmonary artery pressure
References
Nagueh SF (2020) Left ventricular diastolic function: understanding pathophysiology, diagnosis, and prognosis with echocardiography. JACC Cardiovasc Imaging 13:228–244
Obokata M, Reddy YNV, Borlaug BA (2020) Diastolic dysfunction and heart failure with preserved ejection fraction: understanding mechanisms by using noninvasive methods. JACC Cardiovasc Imaging 13:245–257
Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891–975
Harjola VP, Mullens W, Banaszewski M et al (2017) Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail 19:821–836
Kindermann M (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28:2686 author reply 2686-2687
Andersen OS, Smiseth OA, Dokainish H et al (2017) Estimating left ventricular filling pressure by echocardiography. J Am Coll Cardiol 69:1937–1948
Leng S, Dong Y, Wu Y et al (2019) Impaired cardiovascular magnetic resonance-derived rapid semiautomated right atrial longitudinal strain is associated with decompensated hemodynamics in pulmonary arterial hypertension. Circ Cardiovasc Imaging 12:e008582
Pellicori P, Platz E, Dauw J et al (2020) Ultrasound imaging of congestion in heart failure: examinations beyond the heart. Eur J Heart Fail
Marwick TH, Shah SJ, Thomas JD (2019) Myocardial strain in the assessment of patients with heart failure: a review. JAMA Cardiol 4:287–294
Lancellotti P, Galderisi M, Edvardsen T et al (2017) Echo-Doppler estimation of left ventricular filling pressure: results of the multicentre EACVI Euro-Filling study. Eur Heart J Cardiovasc Imaging 18:961–968
Skrok J, Shehata ML, Mathai S et al (2012) Pulmonary arterial hypertension: MR imaging-derived first-pass bolus kinetic parameters are biomarkers for pulmonary hemodynamics, cardiac function, and ventricular remodeling. Radiology 263:678–687
Swift AJ, Telfer A, Rajaram S et al (2014) Dynamic contrast-enhanced magnetic resonance imaging in patients with pulmonary arterial hypertension. Pulm Circ 4:61–70
Cao JJ, Li L, McLaughlin J, Passick M (2018) Prolonged central circulation transit time in patients with HFpEF and HFrEF by magnetic resonance imaging. Eur Heart J Cardiovasc Imaging 19:339–346
Ricci F, Aung N, Thomson R et al (2019) Pulmonary blood volume index as a quantitative biomarker of haemodynamic congestion in hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging 20:1368–1376
Wan K, Sun J, Yang D et al (2018) Left ventricular myocardial deformation on cine MR images: relationship to severity of disease and prognosis in light-chain amyloidosis. Radiology 288:73–80
Yang F, Wang L, Wang J et al (2021) Prognostic value of fast semi-automated left atrial long-axis strain analysis in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 23:36
Little WC, Downes TR (1990) Clinical evaluation of left ventricular diastolic performance. Prog Cardiovasc Dis 32:273–290
Geske JB, Sorajja P, Nishimura RA, Ommen SR (2007) Evaluation of left ventricular filling pressures by Doppler echocardiography in patients with hypertrophic cardiomyopathy: correlation with direct left atrial pressure measurement at cardiac catheterization. Circulation 116:2702–2708
Houard L, Cosyns B, Droogmans S (2019) Old wine in a new bottle: non-invasive quantitative evaluation of pulmonary congestion with pulmonary blood volume index by cardiac magnetic resonance. Eur Heart J Cardiovasc Imaging 20:1377–1378
Vachiéry JL, Tedford RJ, Rosenkranz S et al (2019) Pulmonary hypertension due to left heart disease. Eur Respir J 53
Ugander M, Kanski M, Engblom H et al (2010) Pulmonary blood volume variation decreases after myocardial infarction in pigs: a quantitative and noninvasive MR imaging measure of heart failure. Radiology 256:415–423
Hansch A, Heyne JP, Jung C et al (2012) Quantitative first pass perfusion in cardiovascular magnetic resonance for determination of peak ventricular transit time--a technique for evaluation of heart function. Eur J Radiol 81:e996–e1001
Jones RH, Sabiston DC Jr, Bates BB et al (1972) Quantitative radionuclide angiocardiography for determination of chamber to chamber cardiac transit times. Am J Cardiol 30:855–864
Houard L, Amzulescu MS, Colin G et al (2021) Prognostic value of pulmonary transit time by cardiac magnetic resonance on mortality and heart failure hospitalization in patients with advanced heart failure and reduced ejection fraction. Circ Cardiovasc Imaging 14:e011680
Ricci F, Barison A, Todiere G et al (2018) Prognostic value of pulmonary blood volume by first-pass contrast-enhanced CMR in heart failure outpatients: the PROVE-HF study. Eur Heart J Cardiovasc Imaging 19:896–904
Meier P, Zierler KL (1954) On the theory of the indicator-dilution method for measurement of blood flow and volume. J Appl Physiol 6:731–744
Hannan WJ, Vojacek J, Connell HM et al (1981) Radionuclide determined pulmonary blood volume in ischaemic heart disease. Thorax 36:922–927
Ait Ali L, Aquaro GD, Peritore G et al (2019) Cardiac magnetic resonance evaluation of pulmonary transit time and blood volume in adult congenital heart disease. J Magn Reson Imaging 50:779–786
Funding
This work was supported by the 1·3·5 Project for Disciplines of Excellence–Clinical Research Incubation Project, West China Hospital, Sichuan University (Grant No. ZYJC18013 and Grant No. Z2018A08)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Yucheng Chen.
Conflict of interest
The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was obtained from all patients in this study.
Ethical approval
Institutional Review Board approval was obtained.
Methodology
• Retrospective
• Observational
• Performed at one institution
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Guo, X., Gong, C., Song, R. et al. First-pass perfusion cardiovascular magnetic resonance parameters as surrogate markers for left ventricular diastolic dysfunction: a validation against cardiac catheterization. Eur Radiol 32, 8131–8139 (2022). https://doi.org/10.1007/s00330-022-08938-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-022-08938-6